Reach Us +44 118 315 0749

Abstract

Evaluation of Dexamethasone Effects in Covid-19 Treatment

(COVID-19) Corona virus disease 2019 is related to severe lung damage and it is likely to cause multi-organ failure, finding a definitive treatment challenging researchers worldwide. Recently dexamethasone has demonstrated significant effects in COVID-19; it reduced mortality and improved recovery. It suppresses immune response and inhibits inflammatory factors, and hence it reduces inflammation and prevents progression to severe form of COVID-19 that caused by excessive cytokine release. Indeed, current evidence about dexamethasone role in the management of COVID-19 is insufficient. The pathophysiology of COVID-19 and dexamethasone action are key points behind its contribution in the treatment of this panepidemic.


Author(s): Hamza Khalifa

Abstract | Full-Text | PDF

Share This Article
30+ Million Readerbase
Google Scholar citation report
Citations : 82

American Journal of Pharmacology and Pharmacotherapeutics received 82 citations as per Google Scholar report

Abstracted/Indexed in
  • Google Scholar
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Directory of Research Journal Indexing (DRJI)
  • IndianScience.in
  • Jour Informatics
  • CiteSeerx
  • American Standards for Journals and Research (ASJR)
  • InfoBase Index
  • Secret Search Engine Labs
  • Euro Pub

View More »

Flyer image